Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery

NCT00493025 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

19

Enrollment

OTHER

Sponsor class

Stopped Closed due to early stopping rule-Low accrual

Conditions

Esophageal Cancer

Interventions

DRUG: cisplatin
DRUG: gefitinib
DRUG: paclitaxel
PROCEDURE: adjuvant therapy
RADIATION: radiation therapy

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]